SEC Form 4 · accession 0001567619-19-004790
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Feb 15, 2019
Accepted (ET)
Feb 19, 2019 · 1:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Feb 15, 2019 | F | 832 | $100.45 | D | 81,257 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 2/16/2017.